Patients who underwent single-port thoracoscopic lung cancer resection after paravertebral nerve block
Conditions
Interventions
Liposomal Bupivacaine mixed with Ropivacaine Group(Group L):None
Liposomal Bupivacaine Combined with Bupivacaine Hydrochloride Group (Group B):None
Ropivacaine Hydrochloride Group (Group R):None
Sponsors
Peking University First Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Age >= 18 years old and <= 65 years old; no restriction on gender; 2.Patients who underwent single-port thoracoscopic lung cancer resection after paravertebral nerve block; 3.ASA class I–II; 4.No hepatic or renal dysfunction; 5.No psychiatric disorders or cognitive impairments; 6.Received postoperative intravenous patient-controlled analgesia; 7.Had complete clinical data available for retrospective analysis;
Exclusion criteria
Exclusion criteria: 1.Patients with unclear ultrasound-guided paravertebral nerve block; 2.Patients with preoperative chronic opioid dependence or long-term use of various types of analgesics (more than 3 months), such as those with chronic low back pain; 3.Preoperative use of antipsychotic medications; 4.Alcohol and/or drug abuse; 5.Use of other drugs during surgery that may affect analgesia, such as esketamine or dexmedetomidine;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative Day 1 activity NRS pain intensity score; | — |
Secondary
| Measure | Time frame |
|---|---|
| NRS pain intensity rating;Postoperative pain pump sufentanil dosage;Supplementary dosage of pain relief medication in the ward; | — |
Countries
China
Contacts
Public ContactSong Linlin
Peking University First Hospital
Outcome results
None listed